Oracle Investment Management
Latest statistics and disclosures from Oracle Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BHVN, Pacific Biosciences Calif In, Teladoc Inc call, PACB, QDEL, and represent 53.82% of Oracle Investment Management's stock portfolio.
- Added to shares of these 10 stocks: Teladoc Inc call (+$14M), EYPT (+$9.3M), Springworks Therapeutics (+$9.1M), Ardelyx Inc call (+$8.8M), SWTX (+$5.7M), Eyepoint Pharmaceuticals (+$5.1M), BHVN, Walgreens Boots Alliance, TDOC, ARDX.
- Started 8 new stock positions in Eyepoint Pharmaceuticals, EYPT, Springworks Therapeutics, SWTX, Walgreens Boots Alliance, Ardelyx Inc call, TDOC, Teladoc Inc call.
- Reduced shares in these 10 stocks: Quidelortho Corp (-$125M), Pacific Biosciences Calif In (-$72M), Biohaven (-$64M), Quidelortho Corp (-$7.3M), PACB, WGS, MNKD, QDEL, NSTGQ, .
- Sold out of its positions in Quidelortho Corp, MNKD, NSTGQ, OMGA, OPK.
- Oracle Investment Management was a net seller of stock by $-215M.
- Oracle Investment Management has $164M in assets under management (AUM), dropping by -49.53%.
- Central Index Key (CIK): 0001012622
Tip: Access up to 7 years of quarterly data
Positions held by Oracle Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 26 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Biohaven (BHVN) | 18.6 | $31M | +17% | 716k | 42.80 |
|
| Pacific Biosciences Calif In Call Call Option | 10.7 | $18M | -80% | 1.8M | 9.81 |
|
| Teladoc Health Call Call Option | 8.4 | $14M | NEW | 640k | 21.55 |
|
| Pacific Biosciences of California (PACB) | 8.2 | $14M | -15% | 1.4M | 9.81 |
|
| Quidel Corp (QDEL) | 7.9 | $13M | -7% | 177k | 73.70 |
|
| Quidelortho Corp Call Call Option | 7.7 | $13M | -90% | 172k | 73.70 |
|
| Eyepoint Pharmaceuticals Com New (EYPT) | 5.6 | $9.3M | NEW | 402k | 23.11 |
|
| Springworks Therapeutics Call Call Option | 5.5 | $9.1M | NEW | 250k | 36.50 |
|
| Ardelyx Call Call Option | 5.4 | $8.8M | NEW | 1.4M | 6.20 |
|
| Springworks Therapeutics (SWTX) | 3.5 | $5.7M | NEW | 157k | 36.50 |
|
| Ardelyx (ARDX) | 3.3 | $5.4M | +15% | 865k | 6.20 |
|
| Eyepoint Pharmaceuticals Call Call Option | 3.1 | $5.1M | NEW | 220k | 23.11 |
|
| Forian Ord (FORA) | 2.4 | $4.0M | 1.4M | 2.92 |
|
|
| Biohaven Call Call Option | 2.0 | $3.2M | -95% | 75k | 42.80 |
|
| BioCryst Pharmaceuticals (BCRX) | 2.0 | $3.2M | -3% | 536k | 5.99 |
|
| Walgreens Boots Alliance Call Call Option | 1.6 | $2.6M | NEW | 100k | 26.11 |
|
| Teladoc (TDOC) | 1.5 | $2.4M | NEW | 113k | 21.55 |
|
| Immutep Sponsored Ads (IMMP) | 0.8 | $1.2M | 516k | 2.40 |
|
|
| Agenus Com New (AGEN) | 0.7 | $1.2M | -33% | 1.4M | 0.83 |
|
| Biogen Idec (BIIB) | 0.4 | $624k | 2.4k | 258.77 |
|
|
| Genedx Holdings Corp Com Cl A (WGS) | 0.3 | $491k | -82% | 178k | 2.75 |
|
| Accelerate Diagnostics Com New (AXDX) | 0.3 | $437k | -18% | 112k | 3.92 |
|
| Vertex Energy (VTNR) | 0.1 | $170k | +97% | 50k | 3.39 |
|
| Biodesix (BDSX) | 0.1 | $112k | +44% | 61k | 1.84 |
|
| Dermtech Ord ord (DMTK) | 0.1 | $84k | 48k | 1.75 |
|
|
| Mink Therapeutics (INKT) | 0.0 | $40k | 37k | 1.07 |
|
Past Filings by Oracle Investment Management
SEC 13F filings are viewable for Oracle Investment Management going back to 2010
- Oracle Investment Management 2023 Q4 filed Feb. 14, 2024
- Oracle Investment Management 2023 Q3 filed Nov. 14, 2023
- Oracle Investment Management 2023 Q2 filed Aug. 14, 2023
- Oracle Investment Management 2023 Q1 filed May 15, 2023
- Oracle Investment Management 2022 Q4 filed Feb. 14, 2023
- Oracle Investment Management 2022 Q3 filed Nov. 14, 2022
- Oracle Investment Management 2022 Q2 filed Aug. 15, 2022
- Oracle Investment Management 2022 Q1 filed May 16, 2022
- Oracle Investment Management 2021 Q4 filed Feb. 14, 2022
- Oracle Investment Management 2021 Q3 filed Nov. 15, 2021
- Oracle Investment Management 2021 Q2 filed Aug. 16, 2021
- Oracle Investment Management 2021 Q1 filed May 17, 2021
- Oracle Investment Management 2020 Q4 filed Feb. 16, 2021
- Oracle Investment Management 2020 Q3 filed Nov. 16, 2020
- Oracle Investment Management 2020 Q2 filed Aug. 14, 2020
- Oracle Investment Management 2020 Q1 filed May 15, 2020